These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16575740)

  • 21. Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.
    Barchiesi F; Hollis RJ; Del Poeta M; McGough DA; Scalise G; Rinaldi MG; Pfaller MA
    Clin Infect Dis; 1995 Sep; 21(3):561-4. PubMed ID: 8527544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and treatment management of oropharyngeal candidiasis in cancer patients: results of the French CANDIDOSCOPE study.
    Gligorov J; Bastit L; Gervais H; Henni M; Kahila W; Lepille D; Luporsi E; Sasso G; Varette C; Azria D;
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):532-9. PubMed ID: 20594986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Voriconazole resistant Candida spp. and Saccharomyces spp. isolates from oropharyngeal candidiasis from Cambodian children with AIDS not pretreated with azoles (letter).
    Shahum A; Liskova A; Kalavsky E; Krcmery V
    Scand J Infect Dis; 2007; 39(3):286-7. PubMed ID: 17366071
    [No Abstract]   [Full Text] [Related]  

  • 24. Rationalizing prescribing for oral and oesophageal candidiasis.
    Taylor CB; Finlay R; Richardson C; Bunting P; Welch J
    Int J STD AIDS; 1996 Oct; 7(6):452. PubMed ID: 8940678
    [No Abstract]   [Full Text] [Related]  

  • 25. Candidiasis at ICAAC.
    Barr D; Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of all antifungal therapy for infection due to Candida albicans: a new AIDS-related problem?
    Landman D; Saurina G; Quale JM
    Clin Infect Dis; 1998 Jan; 26(1):183-4. PubMed ID: 9455530
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fluconazole in the treatment of esophageal, bronchial and oral candidiasis in patients with ARC and AIDS].
    Gritti FM; Raise E; Di Salvo S; Vannini V; Lanzoni G; Cucci AM
    G Ital Chemioter; 1988; 35(1-3):61-8. PubMed ID: 2855730
    [No Abstract]   [Full Text] [Related]  

  • 28. Oropharyngeal candidiasis.
    Pankhurst C
    Clin Evid; 2002 Jun; (7):1248-62. PubMed ID: 12230743
    [No Abstract]   [Full Text] [Related]  

  • 29. The diagnosis and treatment of candidiasis: current therapeutic options.
    Filler SG
    AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S10-4; discussion S15. PubMed ID: 11361745
    [No Abstract]   [Full Text] [Related]  

  • 30. Candida infection in HIV positive patients 1985-2007.
    Traeder C; Kowoll S; Arastéh K
    Mycoses; 2008 Sep; 51 Suppl 2():58-61. PubMed ID: 18721333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans.
    Li X; Brown N; Chau AS; López-Ribot JL; Ruesga MT; Quindos G; Mendrick CA; Hare RS; Loebenberg D; DiDomenico B; McNicholas PM
    J Antimicrob Chemother; 2004 Jan; 53(1):74-80. PubMed ID: 14657086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility.
    Makarova NU; Pokrowsky VV; Kravchenko AV; Serebrovskaya LV; James MJ; McNeil MM; Lasker BA; Warnock DW; Reiss E
    J Clin Microbiol; 2003 May; 41(5):1833-7. PubMed ID: 12734213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perillaldehyde: A promising antifungal agent to treat oropharyngeal candidiasis.
    Chen L; Qu S; Yang K; Liu M; Li YX; Keller NP; Zeng X; Tian J
    Biochem Pharmacol; 2020 Oct; 180():114201. PubMed ID: 32822688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients.
    Graybill JR; Vazquez J; Darouiche RO; Morhart R; Greenspan D; Tuazon C; Wheat LJ; Carey J; Leviton I; Hewitt RG; MacGregor RR; Valenti W; Restrepo M; Moskovitz BL
    Am J Med; 1998 Jan; 104(1):33-9. PubMed ID: 9528717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candida dubliniensis in radiation-induced oropharyngeal candidiasis.
    Redding SW; Bailey CW; Lopez-Ribot JL; Kirkpatrick WR; Fothergill AW; Rinaldi MG; Patterson TF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):659-62. PubMed ID: 11402278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
    Fortun Abete J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():4-14. PubMed ID: 9441305
    [No Abstract]   [Full Text] [Related]  

  • 37. Candidiasis (oropharyngeal).
    Pankhurst CL
    Clin Evid; 2006 Jun; (15):1849-63. PubMed ID: 16973067
    [No Abstract]   [Full Text] [Related]  

  • 38. Posaconazole: new indications. Prevention of invasive mycosis and treatment of oropharyngeal candidiasis: no therapeutic advantage.
    Prescrire Int; 2008 Dec; 17(98):233. PubMed ID: 19422144
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluconazole versus ketoconazole in oropharyngeal candidiasis in AIDS.
    Lancet; 1989 May; 1(8647):1130-1. PubMed ID: 2566063
    [No Abstract]   [Full Text] [Related]  

  • 40. Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues.
    Darouiche RO
    Clin Infect Dis; 1998 Feb; 26(2):259-72; quiz 273-4. PubMed ID: 9502438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.